scholarly journals 167 INZ-701 prevents ectopic mineralization in an Abcc6 mouse model of pseudoxanthoma elasticum

2021 ◽  
Vol 141 (5) ◽  
pp. S30
Author(s):  
J.D. Jacobs ◽  
Q. Li ◽  
Z. Cheng ◽  
K. O'Brien ◽  
D. Thompson ◽  
...  
Bone Reports ◽  
2021 ◽  
Vol 14 ◽  
pp. 100768
Author(s):  
Zhiliang Cheng ◽  
Joely D. Jacobs ◽  
Kevin O'Brien ◽  
David Thompson ◽  
Jouni Uitto ◽  
...  

2010 ◽  
Vol 130 (5) ◽  
pp. 1288-1296 ◽  
Author(s):  
Qiujie Jiang ◽  
Florian Dibra ◽  
Michael D. Lee ◽  
Reid Oldenburg ◽  
Jouni Uitto

2020 ◽  
Vol 3 (2) ◽  
pp. 91-96
Author(s):  
Jing-Yi Zhao ◽  
Joshua Kingman ◽  
Ida Joely Jacobs ◽  
Jouni Uitto ◽  
Yi Cao ◽  
...  

Oncotarget ◽  
2018 ◽  
Vol 9 (56) ◽  
pp. 30721-30730 ◽  
Author(s):  
Qiaoli Li ◽  
Joshua Kingman ◽  
John P. Sundberg ◽  
Michael A. Levine ◽  
Jouni Uitto

2020 ◽  
Vol 22 (1) ◽  
pp. 278
Author(s):  
Jianjian Sun ◽  
Peilu She ◽  
Xu Liu ◽  
Bangjun Gao ◽  
Daqin Jin ◽  
...  

Pseudoxanthoma elasticum (PXE), caused by ABCC6/MRP6 mutation, is a heritable multisystem disorder in humans. The progressive clinical manifestations of PXE are accompanied by ectopic mineralization in various connective tissues. However, the pathomechanisms underlying the PXE multisystem disorder remains obscure, and effective treatment is currently available. In this study, we generated zebrafish abcc6a mutants using the transcription activator-like effector nuclease (TALEN) technique. In young adult zebrafish, abcc6a is expressed in the eyes, heart, intestine, and other tissues. abcc6a mutants exhibit extensive calcification in the ocular sclera and Bruch’s membrane, recapitulating part of the PXE manifestations. Mutations in abcc6a upregulate extracellular matrix (ECM) genes, leading to fibrotic heart with reduced cardiomyocyte number. We found that abcc6a mutation reduced levels of both vitamin K and pyrophosphate (PPi) in the serum and diverse tissues. Vitamin K administration increased the gamma-glutamyl carboxylated form of matrix gla protein (cMGP), alleviating ectopic calcification and fibrosis in vertebrae, eyes, and hearts. Our findings contribute to a comprehensive understanding of PXE pathophysiology from zebrafish models.


2021 ◽  
Vol 22 (6) ◽  
pp. 2858
Author(s):  
Faustino Bisaccia ◽  
Prashant Koshal ◽  
Vittorio Abruzzese ◽  
Maria Antonietta Castiglione Morelli ◽  
Angela Ostuni

Pseudoxanthoma elasticum (PXE) is a complex autosomal recessive disease caused by mutations of ABCC6 transporter and characterized by ectopic mineralization of soft connective tissues. Compared to the other ABC transporters, very few studies are available to explain the structural components and working of a full ABCC6 transporter, which may provide some idea about its physiological role in humans. Some studies suggest that mutations of ABCC6 in the liver lead to a decrease in some circulating factor and indicate that PXE is a metabolic disease. It has been reported that ABCC6 mediates the efflux of ATP, which is hydrolyzed in PPi and AMP; in the extracellular milieu, PPi gives potent anti-mineralization effect, whereas AMP is hydrolyzed to Pi and adenosine which affects some cellular properties by modulating the purinergic pathway. Structural and functional studies have demonstrated that silencing or inhibition of ABCC6 with probenecid changed the expression of several genes and proteins such as NT5E and TNAP, as well as Lamin, and CDK1, which are involved in cell motility and cell cycle. Furthermore, a change in cytoskeleton rearrangement and decreased motility of HepG2 cells makes ABCC6 a potential target for anti-cancer therapy. Collectively, these findings suggested that ABCC6 transporter performs functions that modify both the external and internal compartments of the cells.


2019 ◽  
Vol 189 (2) ◽  
pp. 216-225 ◽  
Author(s):  
Qiaoli Li ◽  
Koen van de Wetering ◽  
Jouni Uitto

Sign in / Sign up

Export Citation Format

Share Document